Cockroach allergy appears early in life in inner-city children with recurrent wheezing

H Alp1, B H Yu, E N Grant

  • 1Department of Pediatrics, Cook County Children's Hospital, Chicago, Illinois 60612, USA.

Insights

Cockroach allergy is common in young children with asthma, appearing as early as 6 months. This sensitivity may be the sole allergen trigger for many inner-city children, highlighting early exposure risks.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Asthma Research

Background:

  • Cockroach allergy and high allergen exposure are linked to rising asthma issues in urban children.
  • Limited data exist on cockroach allergy prevalence in infants and young children with asthma.

Purpose of the Study:

  • To investigate the hypothesis that cockroach allergy develops early in children experiencing recurrent wheezing.
  • To assess the prevalence and timing of cockroach allergen sensitivity in pediatric asthma patients.

Main Methods:

  • Retrospective review of 196 children (5 months–16 years) with recurrent wheezing.
  • Categorization into two age groups: under 4 years and 4–16 years.
  • IgE skin testing for aeroallergens, with specific focus on cockroach allergen in younger children.

Main Results:

  • 23.8% of children under 4 years showed cockroach allergen sensitivity, significantly higher than dust mite sensitivity (12.7%).
  • The youngest child with cockroach sensitivity was 6 months old.
  • 14.3% of young children were monosensitized to cockroach allergen, compared to 4.8% for dust mites.

Conclusions:

  • Cockroach allergen sensitivity is prevalent in early childhood, often preceding other allergies.
  • Cockroach allergy may be a primary or sole allergen in young, inner-city children with asthma.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...